8-K 1 merckkgaahealthcare.htm MERCK KGAA'S CONSUMER HEALTH CARE BUSINESS ACQUISITION

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934
 
 
 
 
 
Date of Report (Date of earliest event reported)
April 19, 2018
 
 
 
 
THE PROCTER & GAMBLE COMPANY
(Exact name of registrant as specified in its charter)
 
Ohio
 
1-434
 
31-0411980
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification Number)

One Procter & Gamble Plaza, Cincinnati, Ohio
 
45202
(Address of principal executive offices)
 
Zip Code

(513) 983-1100
 
45202
(Registrant's telephone number, including area code)
 
Zip Code
 
 
 
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
  
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
 
                                                                                                                                                                                                                            Emerging growth company
 ☐
       
  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐ 
                                                                                                                                  
 
 
 
ITEM 7.01    REGULATION FD DISCLOSURE
 
On April 19, 2018, The Procter & Gamble Company (the "Company") issued a press release with respect to the Company's agreement to acquire Merck KGaA's Consumer Health business.
This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure." 
ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS
 
 
Exhibit Number
 
Description
99.1
 
 
 News Release by The Procter & Gamble Company dated April 19, 2018.
 
 
 SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
                                     THE PROCTER & GAMBLE COMPANY


                                                        BY:  /s/ Sandra T. Lane                    
                                                              Sandra T. Lane
                                                              Assistant Secretary
                                                              April 19, 2018
 

INDEX TO EXHIBIT(S)